Long-Term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights From VALOR-HCM Trial.

Authors

Milind Y Desai
Anjali Owens
Sara Saberi
Andrew Wang
Kathy Wolski
Paul C Cremer
Neal K Lakdawala
Albree Tower-Rader
Mark Zenker
David Fermin, Corewell Health West

Document Type

Article

Publication Date

3-31-2025

Publication Title

Circulation. Genomic and precision medicine

First Page

e005100

Recommended Citation

Desai MY, Owens A, Saberi S, Wang A, Wolski K, Cremer PC, et al [ Fermin D] Long-term effects of mavacamten on patients based on hypertrophic cardiomyopathy pathogenic genetic variant status: insights from VALOR-HCM trial. Circ Genom Precis Med. 2025 Mar 31:e005100. doi: 10.1161/CIRCGEN.125.005100. Epub ahead of print. PMID: 40163785.

DOI

10.1161/CIRCGEN.125.005100

ISSN

2574-8300

PubMed ID

40163785